These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 19584290)

  • 1. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
    Xu H; Cheung IY; Guo HF; Cheung NK
    Cancer Res; 2009 Aug; 69(15):6275-81. PubMed ID: 19584290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications.
    Calabrò L; Sigalotti L; Fonsatti E; Bertocci E; Di Giacomo AM; Danielli R; Cutaia O; Colizzi F; Covre A; Mutti L; Natali PG; Maio M
    J Cell Physiol; 2011 Oct; 226(10):2595-600. PubMed ID: 21792917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy.
    Wang J; Chen X; Xie C; Sun M; Hu C; Zhang Z; Luan L; Zhou J; Zhou J; Zhu X; Ouyang J; Dong X; Li D; Zhang J; Zhao X
    Mol Biotechnol; 2021 Sep; 63(9):849-861. PubMed ID: 34100183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical importance of B7-H3 expression in human pancreatic cancer.
    Yamato I; Sho M; Nomi T; Akahori T; Shimada K; Hotta K; Kanehiro H; Konishi N; Yagita H; Nakajima Y
    Br J Cancer; 2009 Nov; 101(10):1709-16. PubMed ID: 19844235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by Targeting B7-H3 in Cervical Cancer.
    Yang X; Feng KX; Li H; Wang L; Xia H
    Technol Cancer Res Treat; 2020; 19():1533033820942245. PubMed ID: 32856542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3.
    Ahmed M; Cheng M; Zhao Q; Goldgur Y; Cheal SM; Guo HF; Larson SM; Cheung NK
    J Biol Chem; 2015 Dec; 290(50):30018-29. PubMed ID: 26487718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites.
    Kobori H; Hashiguchi M; Piao J; Kato M; Ritprajak P; Azuma M
    Immunology; 2010 Jul; 130(3):363-73. PubMed ID: 20141543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-187, down-regulated in clear cell renal cell carcinoma and associated with lower survival, inhibits cell growth and migration though targeting B7-H3.
    Zhao J; Lei T; Xu C; Li H; Ma W; Yang Y; Fan S; Liu Y
    Biochem Biophys Res Commun; 2013 Aug; 438(2):439-44. PubMed ID: 23916610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior pituitary progenitor cells express costimulatory molecule 4Ig-B7-H3.
    Nagai Y; Aso H; Ogasawara H; Tanaka S; Taketa Y; Watanabe K; Ohwada S; Rose MT; Kitazawa H; Yamaguchi T
    J Immunol; 2008 Nov; 181(9):6073-81. PubMed ID: 18941196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4IgB7-H3 is the major isoform expressed on immunocytes as well as malignant cells.
    Zhou YH; Chen YJ; Ma ZY; Xu L; Wang Q; Zhang GB; Xie F; Ge Y; Wang XF; Zhang XG
    Tissue Antigens; 2007 Aug; 70(2):96-104. PubMed ID: 17610414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-29c downregulates tumor-expressed B7-H3 to mediate the antitumor NK-cell functions in ovarian cancer.
    Deng M; Wu D; Zhang Y; Jin Z; Miao J
    Gynecol Oncol; 2021 Jul; 162(1):190-199. PubMed ID: 33875234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H3 in tumors: friend or foe for tumor immunity?
    Li G; Quan Y; Che F; Wang L
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):245-253. PubMed ID: 29299639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.
    Castriconi R; Dondero A; Augugliaro R; Cantoni C; Carnemolla B; Sementa AR; Negri F; Conte R; Corrias MV; Moretta L; Moretta A; Bottino C
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12640-5. PubMed ID: 15314238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an Fc-enhanced anti-B7-H3 monoclonal antibody with potent antitumor activity.
    Loo D; Alderson RF; Chen FZ; Huang L; Zhang W; Gorlatov S; Burke S; Ciccarone V; Li H; Yang Y; Son T; Chen Y; Easton AN; Li JC; Rillema JR; Licea M; Fieger C; Liang TW; Mather JP; Koenig S; Stewart SJ; Johnson S; Bonvini E; Moore PA
    Clin Cancer Res; 2012 Jul; 18(14):3834-45. PubMed ID: 22615450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
    Cheung IY; Farazi TA; Ostrovnaya I; Xu H; Tran H; Mihailovic A; Tuschl T; Cheung NK
    Genes Chromosomes Cancer; 2014 Oct; 53(10):803-14. PubMed ID: 24898736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma.
    Sun J; Chen LJ; Zhang GB; Jiang JT; Zhu M; Tan Y; Wang HT; Lu BF; Zhang XG
    Cancer Immunol Immunother; 2010 Aug; 59(8):1163-71. PubMed ID: 20333377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miR-29 family facilitates the activation of NK-cell immune responses by targeting the B7-H3 immune checkpoint in neuroblastoma.
    Pathania AS; Chava H; Chaturvedi NK; Chava S; Byrareddy SN; Coulter DW; Challagundla KB
    Cell Death Dis; 2024 Jun; 15(6):428. PubMed ID: 38890285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H3 over expression in prostate cancer promotes tumor cell progression.
    Yuan H; Wei X; Zhang G; Li C; Zhang X; Hou J
    J Urol; 2011 Sep; 186(3):1093-9. PubMed ID: 21784485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.
    Steinberger P; Majdic O; Derdak SV; Pfistershammer K; Kirchberger S; Klauser C; Zlabinger G; Pickl WF; Stöckl J; Knapp W
    J Immunol; 2004 Feb; 172(4):2352-9. PubMed ID: 14764704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.